Results 101 to 110 of about 892,952 (209)

The post-pandemic pivot: mRNA therapeutics enter the chronic rare disease arena. [PDF]

Mol Ther Nucleic Acids
Giangrande PH.
europepmc   +1 more source

Preliminary User-Centred Evaluation of a Bio-Cooperative Robotic Platform for Cognitive Rehabilitation in Parkinson's Disease and Mild Cognitive Impairment: Insights from a Focus Group and Living Lab in the OPERA Project. [PDF]

J Clin Med
Crocetto Y, Abagnale S, Martinelli G, Della Bella S, Pavan E, Rondoni C, Voscarelli A, Pirini M, Scotto di Luzio F, Zollo L, Cicarelli G, Polito C, Estraneo A.   +12 more
europepmc   +1 more source

Optimising Primary thErapy in pRimAry biliary cholangitis (OPERA): protocol for a randomised, double-blind, placebo-controlled trial of enhanced primary therapy with obeticholic acid. [PDF]

BMJ Open
Dunn S, Evans L, Kennedy C, Wafer R, Moody S, Wolstenhulme F, Burton E, Konkoth AB, Fisher H, Chadwick T, Banham A, Hale F, Christie M, Barclay ST, Dyson J, Smith R, Aithal G, Culver E, Aspinall R, Thorburn D, Heneghan M, Hancock HC, Trivedi P, Mells G, Wason J, Jones DEJ.   +25 more
europepmc   +1 more source

Dissecting endometrial cancer complexity in response to standard and targeted therapies. [PDF]

Cell Death Dis
Vaccarella S, Bruno V, Orlandi G, Covino DA, Frascolla C, Pulito C, Vizza R, Urbani G, Allegretti M, De Pascale V, Goeman F, Ciuffreda L, Arteni BAM, Di Martino S, Sacconi A, Mancini E, Bagnato A, Baiocco E, Kajal R, Vinik Y, Lev S, Fanciulli M, Vidiri A, Carosi M, Strano S, Donzelli S, Vizza E, Blandino G.   +27 more
europepmc   +1 more source

Uncovering a bias in estimated treatment effects on PIRA in multiple sclerosis clinical trials. [PDF]

EBioMedicine
Montobbio N, Bovis F, Signori A, Carmisciano L, Schiavetti I, Ponzano M, Tur C, Granziera C, Cagol A, Arnold DL, Kappos L, Sormani MP.   +11 more
europepmc   +1 more source

Ocrelizumab in early relapsing-remitting multiple sclerosis: first interim analysis of the MUSPO Italian prospective cohort. [PDF]

J Neurol
Filippi M, D'Amico E, Brescia Morra V, Zanetta C, Zanghì A, Di Filippo PS, Longobardi E, Colombo E, Mirabella M, Conte A, Tomassini V, Masini C, Perosino V, Tortorella P, Rocca MA, MUPSO Study Group.   +15 more
europepmc   +1 more source

Integrated screening for small molecules interfering with PKM2: a drug repurposing strategy against glioblastoma. [PDF]

J Transl Med
Costantini S, Romeo I, Fanelli G, Roca MS, Gualtieri G, Bagnara P, Polo A, Di Gennaro E, Ortuso F, Alcaro S, Budillon A, Ciliberto G, Paggi MG, Abbruzzese C.   +13 more
europepmc   +1 more source

Perceived vibrato and the singing power ratio explain overall evaluations in opera singing. [PDF]

Front Psychol
Kondo H, Kondoh S, Fujii S.
europepmc   +1 more source

Patients' Associations as Co-Creators of Knowledge: Insights From a Community-Based Participatory Research Study (ProSafe Project). [PDF]

Health Sci Rep
Moretti F, Colpo S, Montresor S, Facchinello D, Robello R, Mazzi M, Tardivo S, Stagi L, Stefano L, Zotti A, Ambroso L, Destro C, Leone S, Petruzzelli D, Moretti U, Rimondini M.   +15 more
europepmc   +1 more source

Cost-Consequence Analysis of Natalizumab Compared with Other High-Efficacy Treatments in Patients with Relapsing-Remitting Multiple Sclerosis. [PDF]

Pharmacoeconomics
Prosperini L, Brescia Morra VB, Fornari C, Santoni L, Perini D, Bergamaschi R, Cortesi PA.   +6 more
europepmc   +1 more source